Press release
United States Over The Counter (OTC) Drugs Market Size to Grow US$ 32.9 Billion by 2028, CAGR of 5.2% | IMARC Group
IMARC Group's report titled "United States Over The Counter (OTC) Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". The United States over the counter (OTC) drugs market size reached US$ 24.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/united-states-over-the-counter-drugs-market/requestsample
Factors Affecting the Growth of the United States Over the Counter Drugs Industry:
• Rising Health Consciousness Among Individuals:
The increasing focus on personal health and wellness among the masses in the United States is propelling the growth of the market. In line with this, people are increasingly becoming health-conscious and are actively seeking ways to manage common health issues. Moreover, people are focusing on the proactive approach to well-being, which is bolstering the market growth. Apart from this, rising preferences for over the counter (OTC) drugs, as they offer a convenient solution for addressing minor ailments without the need from a prescription of a doctor, are impelling the market growth.
• Wide Availability of Over the Counter (OTC) Drugs:
The wide availability of OTC drugs via various online and offline distribution channels in the country is contributing to the growth of the market. In line with this, the easy accessibility of these drugs ensures that people can conveniently purchase the products when they are facing common health issues. Furthermore, the rising number of e-commerce platforms is making these drugs more accessible to a large consumer base in the country. In addition, these online platforms provide doorstep delivery that assists in enhancing the shopping experience among people.
• Growing Demand for Cost-Effective Medications:
The escalating demand for OTC drugs among individuals due to their affordability is offering a positive market outlook in the US. In line with this, people are actively seeking cost-effective alternatives to expensive prescription medications. The lower price of OTC medications makes them an attractive choice for individuals looking to manage their healthcare expenses. Furthermore, OTC drugs are usually consumed for common headaches, allergies, or heartburn to provide rapid relief as compared to visiting a healthcare provider and obtaining a prescription, which is impelling the market growth.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5857&flag=C
United States Over the Counter Drugs Market Trends:
The growing demand for OTC drugs among the geriatric population, as they are more prone to common health issues, is positively influencing the market. Apart from this, these OTC drugs provide convenient and cost-effective solutions, which is contributing to the growth of the market.
The rising focus on maintaining a healthy lifestyle among individuals is bolstering the growth of the market. In line with this, people are increasingly opting for sports-related OTC products like pain relievers and muscle creams, which are propelling the market growth.
United States Over the Counter Drugs Market Report Segmentation:
By Product Type:
• Cough, Cold and Flu Products
• Analgesics
• Dermatology Products
• Gastrointestinal Products
• Vitamins, Minerals and Supplements (VMS)
• Weight-loss/Dietary Products
• Ophthalmic Products
• Sleeping Aids
• Others
Vitamins, minerals, and supplements (VMS) represented the largest segment due to the rising focus on maintaining overall health among individuals.
By Route of Administration:
• Oral
• Parenteral
• Topical
• Others
Oral accounted for the largest market share as it provides quick relief from common ailments.
By Dosage Form:
• Tablets and Capsules
• Liquids
• Ointments
• Others
Tablets and capsules hold the biggest market share due to their enhanced convenience and portability.
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
Retail pharmacies exhibit a clear dominance in the market as OTC drugs are easily available through these stores.
Regional Insights:
• Northeast
• Midwest
• South
• West
West enjoys the leading position in the United States over the counter drugs market on account of the rising trend of self-medication among individuals.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Over The Counter (OTC) Drugs Market Size to Grow US$ 32.9 Billion by 2028, CAGR of 5.2% | IMARC Group here
News-ID: 3332087 • Views: …
More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview
Market Size in 2024: USD 266.2 Million
Market Size in 2033: USD 422.9 Million
Market Growth Rate 2025-2033: 5.3%
According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a…

GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview
Market Size in 2024: USD 73.31 Billion
Market Size in 2033: USD 147.77 Billion
Market Growth Rate 2025-2033: 7.50%
According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by…

GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview
Market Size in 2024: USD 588.2 Million
Market Size in 2033: USD 2,005.3 Million
Market Growth Rate 2025-2033: 13.3%
According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of…

Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview:
The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach…
More Releases for OTC
Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact…
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain adidas AG officers and…
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE
Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services.
The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology…
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,…
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
The…
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF).
Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…